Hepatitis B: Epidemiology and Natural History
Overview
Authors
Affiliations
Chronic infection with hepatitis B and its sequelae remains a major global health concern. Despite recommendations and implementation of vaccination programs, the health and economic burdens are still significant. People in endemic areas and immigrants from these areas need to be adequately screened and treated. HBeAg-negative chronic hepatitis is increasingly recognized with additional challenges in management. Programs implementing primary prophylaxis strategies such as vaccination of high-risk adult and adolescent groups should continue.
Maung S, Decharatanachart P, Treeprasertsuk S, Chaiteerakij R J Clin Exp Hepatol. 2024; 14(4):101388.
PMID: 38523735 PMC: 10956063. DOI: 10.1016/j.jceh.2024.101388.
Modelling the dynamics of acute and chronic hepatitis B with optimal control.
Khan T, Rihan F, Ahmad H Sci Rep. 2023; 13(1):14980.
PMID: 37696844 PMC: 10495432. DOI: 10.1038/s41598-023-39582-9.
Kim N, Cho Y, Kim B, Kim H Dig Dis Sci. 2018; 63(10):2792-2799.
PMID: 29948568 DOI: 10.1007/s10620-018-5165-6.
Mdlalose N, Parboosing R, Moodley P Afr J Lab Med. 2017; 5(1):283.
PMID: 28879104 PMC: 5436393. DOI: 10.4102/ajlm.v5i1.283.
Posuwan N, Payungporn S, Tangkijvanich P, Ogawa S, Murakami S, Iijima S PLoS One. 2014; 9(1):e86007.
PMID: 24465836 PMC: 3900446. DOI: 10.1371/journal.pone.0086007.